424 research outputs found

    ins(9;4)(q33;q12q25)

    Get PDF
    Review on ins(9;4)(q33;q12q25), with data on clinics, and the genes involved

    t(6;12)(q15;p13)

    Get PDF
    Review on t(6;12)(q15;p13

    t(6;10)(q22;q24) NFKB2/ROS1

    Get PDF
    Review on t(6;10)(q22;q24), with data on the genes involved

    t(6;12)(q22;q24) NCOR2/ROS1

    Get PDF
    Review on t(6;12)(q22;q24), with data on the genes involved

    t(1;14)(p35;q32) LAPTM5/IGH

    Get PDF
    Review on t(1;14)(p35;q32), with data on clinics, and the genes involved

    t(9;14)(p24;q12) STRN3/JAK2

    Get PDF
    Review on t(9;14)(p24;q12), with data on clinics, and the genes involved

    t(6;12)(q22;p13) ETV6/FRK

    Get PDF
    Review on t(6;12)(q21;p13), with data on the genes involve

    Langerhans cell sarcoma

    Get PDF
    Tumours derived from Langerhans cells (LCs) are divided into two main subgroups, according to the degree of cytological atypia and clinical aggressiveness: LC histiocytosis (LCH) and LC sarcoma (LCS). LCS is a high-grade neoplasm with obviously malignant cytologic features and the Langerhans cell phenotype, which is rare. Here the clinic-pathological of LCS will be discussed based on reported cases in the literature

    t(14;19)(q32;q13) IGH/Various Partners

    Get PDF
    Review on the various t(14;19)(q32;q13), with data on clinics, and the genes involved
    corecore